Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Takagi

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Nephron|January 1, 1997
Relapsing membranous nephropathy with a good response to steroid therapyY Tsukada, S Yano, T Tanaka, et al.
Diabetes|September 1, 1997
Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitorL P Aiello, S E Bursell, A Clermont, et al.
Science (New York, N.Y.)|May 3, 1996
Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitorH Ishii, M R Jirousek, D Koya, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Nephron|January 1, 1997
Relapsing membranous nephropathy with a good response to steroid therapyY Tsukada, S Yano, T Tanaka, et al.
Diabetes|September 1, 1997
Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitorL P Aiello, S E Bursell, A Clermont, et al.
Science (New York, N.Y.)|May 3, 1996
Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitorH Ishii, M R Jirousek, D Koya, et al.
Pageof 5